MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroprotective effect of α-Mangostin in restoration mitochondrial function in MPTP-Induced Parkinson’s disease in mice

A. Prakash, A.B. Majeed, K. Ramasamy, M. Hasan (Baltimore, MD, USA)

Meeting: 2017 International Congress

Abstract Number: 592

Keywords: 1-Methyl-4-phenylpyridinium (MPP+), Dopamine, Mitochondrial dysfunction

Session Information

Date: Tuesday, June 6, 2017

Session Title: Parkinson's Disease: Pathophysiology

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: The aim of the present study was to explore the protective effect of alpha-mangostin against mitochondrial oxidative stress in MPTP treated mice.

Background: It has been reported that mitochondrial oxidative stress plays a pivotal role in neurodegenerative disease like Parkinson’s disease (PD). Recently, medicinal plant extracts acted as traditional, complementary and potential medicine for PD. Alpha-mangostin (AM) is the main xanthone purified from mangosteen known as anti-oxidative properties.

Methods: MPTP was administered repeatedly on 1st, 7th and 14th day intranigrally for the induction of PD in mice. AM (3 and 6mg/kg) and Selegiline (10 mg/kg) were given intraperitonially, after induction of PD for 14 days. Different behavioral performances were carried on 1st, 14th, 21st, 28th  days and biochemical parameters were estimated on 28th day.

Results: Central administration of MPTP showed significant impairment of motor behavior and marked increase of mitochondria oxidative damage and neuro-inflammation in mice. However, post treatment with AM (3 and 6mg/kg) significantly and dose dependently  improved the motor deficits and attenuated the oxidative damage indicating decreased rise of LPO and nitrite concentration and restored the decreased activities of endogenous antioxidant enzyme (Glutathione, Catalase, SOD) and mitochondria enzymes (NADPH dehydrogenase, Succinic dehydrogenase and cytochrome oxidase) as compared to selegiline effects. In addition AM also attenuates the pro-inflammatory cytokines like TNF-α and IL-β in striatum region of MPTP induced PD in mice.

Conclusions: These results suggested that AM exhibit Neuroprotective effect by mediating brain antioxidant defense mechanism and by up regulating of dopaminergic pathway

To cite this abstract in AMA style:

A. Prakash, A.B. Majeed, K. Ramasamy, M. Hasan. Neuroprotective effect of α-Mangostin in restoration mitochondrial function in MPTP-Induced Parkinson’s disease in mice [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/neuroprotective-effect-of-%ce%b1-mangostin-in-restoration-mitochondrial-function-in-mptp-induced-parkinsons-disease-in-mice/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroprotective-effect-of-%ce%b1-mangostin-in-restoration-mitochondrial-function-in-mptp-induced-parkinsons-disease-in-mice/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley